Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supervised versus unsupervised Suboxone administration for heroin dependence
ACTRN12607000285459Phase 3Completed
- Sponsor
- The Langton Centre
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of Suboxone in heroin addiction and opioid use disorder (OUD) (2 arms), sponsored by The Langton Centre. Primary endpoints: Retention in treatment, Heroin use and 1 more. Started Jan 2004; status: completed.
02
Drugs
Suboxone
03
Conditions
heroin addictionopioid use disorder (OUD)
Beyond the preview
Go deeper on ACTRN12607000285459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000285459.